A carregar...

Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy

One arising challenge in the treatment of breast cancer is development of therapeutic resistance to trastuzumab, an antibody targeting the human epidermal growth factor receptor-2 (HER2) which is frequently amplified in breast cancers. In this study, we provide evidence that elevated level of the re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhuang, Guanglei, Brantley-Sieders, Dana M., Vaught, David, Yu, Jian, Xie, Lu, Wells, Sam, Jackson, Dowdy, Muroaka-Cook, Rebecca, Arteaga, Carlos, Chen, Jin
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3859619/
https://ncbi.nlm.nih.gov/pubmed/20028874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-1845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!